
Feature|Videos|November 19, 2025
The Consequences: When a Guess Becomes a Gamble
Author(s)David Edelman, Thrivable
Learn how outdated or incomplete insights turn every decision into a high-stakes gamble that cost brands money, momentum, and internal alignment.
Advertisement
When leaders rely on old data or partial truths, the fallout can be brutal. Budgets get wasted solving the wrong problem, like targeting market access when the real issue is patient confusion. Opportunities vanish as competitors seize openings before lagging data confirms them. Without a single, trusted source of patient truth, teams lock up in decision paralysis, battle over opinions, and allow the “loudest voice” to dictate strategy. Momentum stalls, alignment fractures, and the brand pays the price.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
2
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge
5





